All times listed are Pacific Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.
- Home
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT(0196–0228) Infection-related Rheumatic Disease PosterLocation: Poster Hall
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0196: Limited Regulatory T Cell Response in Post-Chikungunya Viral Arthritis: A Therapeutic Opportunity?Location: Poster Hall
Abstract Poster Presenter: – GEORGE WASHINGTON UNIVERSITY
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0197: Development of a Chikungunya Arthritis Disease Activity ScoreLocation: Poster Hall
Abstract Poster Presenter: – GEORGE WASHINGTON UNIVERSITY
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0198: Improving Vaccination Uptake of Herpes Zoster in Young Rheumatic Disease Patients Ages 18-49 Using Specialty Pharmacy PartnershipLocation: Poster Hall
Abstract Poster Presenter: – LSU
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0199: Experience in Real-World Conditions of the Effectiveness of the Vaccine Against Herpes Zoster VirusLocation: Poster Hall
Abstract Poster Presenter: – Resident at Hospital Universitari i Politecnic La Fe
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0200: Herpes Zoster Prevalence in Patients with Rheumatic DiseasesLocation: Poster Hall
Abstract Poster Presenter: – Universidad Autonoma de Nuevo Leon
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0201: Tolerability and Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Rheumatic Musculoskeletal Diseases - A Prospective Longitudinal Study over 12 MonthsLocation: Poster Hall
Abstract Poster Presenter: – Rheumazentrum Ruhrgebiet Herne
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0202: Analysis of the Effects of Immunosuppressive Therapy on Herpes Zoster Events After Each of Three Doses of the BNT162b2 mRNA Vaccine in Patients with Spondyloarthritis (SpA)Location: Poster Hall
Abstract Poster Presenter: – Carmel Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0203: Projecting the Impact on Clinical Outcomes in ANCA-Associated Vasculitis of Delaying Retreatment with Rituximab for Vaccine OptimizationLocation: Poster Hall
Abstract Poster Presenter: – Massachusetts General Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0204: Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory DiseasesLocation: Poster Hall
Abstract Poster Presenter: – Universary hospital of montpellier
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0205: Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection with Interferon or Direct Antiviral TherapyLocation: Poster Hall
Abstract Poster Presenter: – School of Medicine, I-Shou University
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0206: Risk of Hepatitis B Virus Reactivation in Patients with Rheumatoid Arthritis Receiving JAK Inhibitor or IL-6 Inhibitor: A Systematic Review and Meta-AnalysisLocation: Poster Hall
Abstract Poster Presenter: – Stanford University
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0207: Role of Pneumocystis Jirovecii Pneumonia Prophylaxis with Trimethoprim-Sulfamethoxazole Among Patients with Autoimmune Inflammatory Diseases Receiving High-Dose Glucocorticoids: A Systematic Review and Meta-AnalysisLocation: Poster Hall
Abstract Poster Presenter: – Warren Alpert Medical School of Brown University
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0208: Pneumocystis Jirovecii Pneumonia (PJP) Prophylaxis (PPX), Investigating the Practice Patterns of Providers for Patients on Chronic, High-Dose Immunosuppression in a Rural Integrated Health SystemLocation: Poster Hall
Abstract Poster Presenter: – Geisinger Medical Center Internal Medicine Residency
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0209: Safety of Bivalent SARS-CoV-2 Vaccines as a Second Booster Dose in Arthritis Patients on Immunosuppressive TherapiesLocation: Poster Hall
Abstract Poster Presenter: – Diakonhjemmet Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0210: Longitudinal T Cell Responses to a Series of Four SARS-CoV-2 Vaccine Doses or COVID-19 in Patients on TNF InhibitorsLocation: Poster Hall
Abstract Poster Presenter: – Diakonhjemmet Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0211: COVID-19 Outcome and Association to Anti-Spike Antibody Levels in Patients on Immunosuppressive Therapy; A Prospective Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Diakonhjemmet Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0212: The Impact of Immunosuppression on the Humoral Immunogenicity of SARS-CoV-2 mRNA Vaccines in SLELocation: Poster Hall
Abstract Poster Presenter: – Duke University
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0213: When Should I Get My Next Booster? Active Surveillance of COVID-19 Breakthrough Infections in Canadian Patients with Immune-Mediated Inflammatory DiseasesLocation: Poster Hall
Abstract Poster Presenter: – University of British Columbia
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0214: COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice NetworkLocation: Poster Hall
Abstract Poster Presenter: – University of Alabama at Birmingham
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0215: Effectiveness of Three Doses of SARS-CoV-2 Vaccines in Brazilian Patients with Systemic Vasculitides: Preliminary Results of a Real-life Prospective CohortLocation: Poster Hall
Abstract Poster Presenter: – UNIFESP
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0216: High Immunogenicity of mRNA Covid-19 Vaccine Booster in Immune Mediated Inflammatory DiseaseLocation: Poster Hall
Abstract Poster Presenter: – NYU Langone Health
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0217: Safety and Efficacy of Tixagevimab/Cilgavimab (Evusheld) in Autoimmune Inflammatory Rheumatic Disease Patients – a Prospective Multicenter Open-label StudyLocation: Poster Hall
Abstract Poster Presenter: – Carmel Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0218: Incidence and Risk Factors for Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients with Systemic Autoimmune Rheumatic DiseasesLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0219: Safety and Efficacy of Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab (Evusheld) in Patients with Autoimmune Diseases and Renal Involvement Who Received RituximabLocation: Poster Hall
Abstract Poster Presenter: – University of Turin
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0220: Paxlovid (Nirmatrelvir Plus Ritonavir) in Patients with Underlying Rheumatological Diseases, in Preventing COVID-19 Related Hospitalization and DeathLocation: Poster Hall
Abstract Poster Presenter: – University of Kentucky
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0221: Post-COVID-19 Autoimmune Serologies and ImmunophenotypesLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0222: Predictors of Adverse Prognosis Following Hospitalization for COVID-19 Infection in Patients with Immune Mediated Inflammatory Diseases Treated with RituximabLocation: Poster Hall
Abstract Poster Presenter: – Taipei City Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0223: Severity and Risk Factors of Hospitalization of Omicron in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Peking University People's Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0224: Risk Factors and Outcomes for Repeat COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Case-control StudyLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0225: Breakthrough SARS-Cov-2 Infection and Disease Flares in Patients with Rheumatoid Arthritis: Result from COVAD E-Survey StudyLocation: Poster Hall
Abstract Poster Presenter: – Centro de Estudios de Reumatología y Dermatología SAS
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0226: Relationships Among Parameters of Mineral Metabolism and Bone Turnover During Acute COVID-related Hospitalization and Subsequent Follow Up: A Pilot StudyLocation: Poster Hall
Abstract Poster Presenter: – Yale School of Medicine
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0227: Associations of DMARDs with Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases: A Prospective StudyLocation: Poster Hall
Abstract Poster Presenter: – Tufts University School of Medicine
Infection-related rheumatic syndromes
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0228: A Comprehensive Retrospective Analysis of Polymyalgia Rheumatica in Long COVID Patients at an Academic Medical Center in the MidwestLocation: Poster Hall
Abstract Poster Presenter: – University of Mississippi Medical Center
Infection-related rheumatic syndromes
-
Monday, Nov 13th
4:00 PM – 5:30 PM PT13M162: Abstracts: Infection-related Rheumatic Disease (1669–1674)Location: Room 6E/6D
Abstract Moderator: – University of Alabama at Birmingham
Abstract Moderator: – Hospital for Special Surgery, Weill Cornell Medicine
Infection-related rheumatic syndromes
-
Monday, Nov 13th
4:00 PM – 4:10 PM PT1669: High Incidence of Immune-mediated Inflammatory Diseases in Sepsis Survivors: A Nationwide Exposed-non-exposed Epidemiological StudyLocation: Room 6E/6D
Presenting Author: – Université Paris Cité
Infection-related rheumatic syndromes
-
Monday, Nov 13th
4:15 PM – 4:25 PM PT1670: Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 SequelaeLocation: Room 6E/6D
Presenting Author: – CLEVELAND CLINIC FOUNDATION
Infection-related rheumatic syndromes
-
Monday, Nov 13th
4:30 PM – 4:40 PM PT1671: Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology PracticeLocation: Room 6E/6D
Presenting Author: – Mayo Clinic
Infection-related rheumatic syndromes
-
Monday, Nov 13th
4:45 PM – 4:55 PM PT1672: Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover StudyLocation: Room 6E/6D
Presenting Author: – Hospital for Special Surgery
Infection-related rheumatic syndromes
-
Monday, Nov 13th
5:00 PM – 5:10 PM PT1673: Immunomodulatory Treatment and Autoimmune Patient Responses to COVID-19 Booster Shots: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) StudyLocation: Room 6E/6D
Presenting Author: – University of Alabama at Birmingham
Infection-related rheumatic syndromes
-
Monday, Nov 13th
5:15 PM – 5:25 PM PT1674: Severe Infections in Patients with VEXAS Syndrome: A Study from the French VEXAS GroupLocation: Room 6E/6D
Presenting Author: – Université Paris-Est Créteil
Infection-related rheumatic syndromes
